secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-08-31T20:59:24+00:00
Accession:  0001493152-26-040845
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X regains Nasdaq equity compliance; monitor period through Aug 2027
-----------------------------------------------------------------------

- Received Nasdaq Panel letter on Aug 28, 2026 confirming compliance with Listing Rule 5550(b)(1) ($2.5M stockholders' equity requirement).
- Securities remain subject to delisting if compliance not maintained until Nov 18, 2026.
- Mandatory panel monitor until Aug 28, 2027; new non-compliance triggers delisting determination without cure period.
- Company may request hearing with Panel if delisting is proposed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/0001493152-26-040845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer